Rivera Jose E
Insider CIK 1671870 · NTLA EVP, General Counsel & Ops
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| NTLA Intellia Therapeutics, Inc | M Exercise deriv | 2021-04-01 | 2021-04-02 | 10,000 | — | $0 | 51,000 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | M Exercise deriv | 2021-04-01 | 2021-04-02 | 33,000 | — | $0 | 39,000 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | M Exercise deriv | 2021-04-01 | 2021-04-02 | 21,000 | — | $0 | 29,090 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | M Exercise deriv | 2021-04-01 | 2021-04-02 | 33,001 | — | $0 | 6,116 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2021-04-01 | 2021-04-02 | 6,768 | $81.87 | $554.1K | 169,344 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2021-04-01 | 2021-04-02 | 1,965 | $80.85 | $158.9K | 176,112 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | M Exercise | 2021-04-01 | 2021-04-02 | 33,001 | $6.83 | $225.4K | 178,077 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2021-04-01 | 2021-04-02 | 123 | $85.14 | $10.5K | 145,076 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2021-04-01 | 2021-04-02 | 1,049 | $83.98 | $88.1K | 145,199 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2021-04-01 | 2021-04-02 | 951 | $82.87 | $78.8K | 146,248 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2021-04-01 | 2021-04-02 | 3,361 | $82.77 | $278.2K | 165,983 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2021-04-01 | 2021-04-02 | 2,258 | $83.85 | $189.3K | 163,725 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2021-04-01 | 2021-04-02 | 1,213 | $84.73 | $102.8K | 162,512 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2021-04-01 | 2021-04-02 | 124 | $85.76 | $10.6K | 162,388 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | M Exercise | 2021-04-01 | 2021-04-02 | 33,000 | $13.88 | $458.0K | 148,842 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2021-04-01 | 2021-04-02 | 2,010 | $80.79 | $162.4K | 146,832 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2021-04-01 | 2021-04-02 | 8,266 | $81.89 | $676.9K | 138,566 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2021-04-01 | 2021-04-02 | 3,233 | $82.76 | $267.6K | 135,333 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2021-04-01 | 2021-04-02 | 3,234 | $83.91 | $271.4K | 132,099 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2021-04-01 | 2021-04-02 | 1,067 | $84.94 | $90.6K | 131,032 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | M Exercise | 2021-04-01 | 2021-04-02 | 21,000 | $18.30 | $384.3K | 152,032 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2021-04-01 | 2021-04-02 | 1,256 | $80.82 | $101.5K | 150,776 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2021-04-01 | 2021-04-02 | 4,818 | $81.83 | $394.3K | 145,958 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2021-04-01 | 2021-04-02 | 2,728 | $82.63 | $225.4K | 143,230 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2021-04-01 | 2021-04-02 | 1,724 | $83.72 | $144.3K | 141,506 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | M Exercise | 2021-04-01 | 2021-04-02 | 10,000 | $14.58 | $145.8K | 150,543 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2021-04-01 | 2021-04-02 | 963 | $84.87 | $81.7K | 140,543 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2021-04-01 | 2021-04-02 | 700 | $80.73 | $56.5K | 149,843 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2021-04-01 | 2021-04-02 | 2,644 | $81.95 | $216.7K | 147,199 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award deriv | 2021-03-03 | 2021-03-05 | 12,250 | — | $0 | 12,250 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award deriv | 2021-03-03 | 2021-03-05 | 73,500 | — | $0 | 73,500 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | M Exercise deriv | 2021-02-09 | 2021-02-09 | 21,000 | — | $0 | 50,090 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | M Exercise | 2021-02-09 | 2021-02-09 | 21,000 | $18.30 | $384.3K | 129,409 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2021-02-09 | 2021-02-09 | 11,489 | $75.00 | $861.7K | 117,920 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | M Exercise deriv | 2021-02-01 | 2021-02-03 | 10,000 | — | $0 | 61,000 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | M Exercise deriv | 2021-02-01 | 2021-02-03 | 66,000 | — | $0 | 39,117 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | M Exercise deriv | 2021-02-01 | 2021-02-03 | 33,000 | — | $0 | 72,000 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2021-02-01 | 2021-02-03 | 755 | $65.07 | $49.1K | 108,409 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2021-02-01 | 2021-02-03 | 2,386 | $64.18 | $153.1K | 109,164 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2021-02-01 | 2021-02-03 | 2,326 | $63.44 | $147.6K | 111,550 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | M Exercise | 2021-02-01 | 2021-02-03 | 10,000 | $14.58 | $145.8K | 113,876 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2021-02-01 | 2021-02-03 | 2,827 | $65.05 | $183.9K | 103,876 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2021-02-01 | 2021-02-03 | 8,366 | $64.16 | $536.8K | 106,703 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2021-02-01 | 2021-02-03 | 6,617 | $63.34 | $419.1K | 115,069 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | M Exercise | 2021-02-01 | 2021-02-03 | 33,000 | $13.88 | $458.0K | 121,686 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2021-02-01 | 2021-02-03 | 5,312 | $65.01 | $345.3K | 88,686 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2021-02-01 | 2021-02-03 | 15,594 | $64.11 | $999.7K | 93,998 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2021-02-01 | 2021-02-03 | 10,476 | $63.31 | $663.2K | 109,592 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | M Exercise | 2021-02-01 | 2021-02-03 | 66,000 | $6.83 | $450.8K | 120,068 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2021-01-05 | 2021-01-05 | 2,078 | $55.86 | $116.1K | 51,990 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award deriv | 2020-12-31 | 2021-01-05 | 4,792 | — | $0 | 4,792 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | M Exercise deriv | 2020-12-31 | 2021-01-05 | 4,792 | — | $0 | 0 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award deriv | 2020-12-31 | 2021-01-05 | 9,583 | — | $0 | 9,583 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | M Exercise | 2020-12-31 | 2021-01-05 | 4,792 | — | $0 | 54,068 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | M Exercise deriv | 2020-12-01 | 2020-12-03 | 5,000 | — | $0 | 105,000 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2020-12-01 | 2020-12-03 | 1,585 | $37.73 | $59.8K | 50,487 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2020-12-01 | 2020-12-03 | 1,522 | $38.49 | $58.6K | 48,965 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2020-12-01 | 2020-12-03 | 257 | $39.46 | $10.1K | 48,708 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | M Exercise | 2020-12-01 | 2020-12-03 | 5,000 | $13.88 | $69.4K | 52,072 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | M Exercise deriv | 2020-11-18 | 2020-11-18 | 848 | — | $0 | 71,090 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2020-11-18 | 2020-11-18 | 624 | $35.00 | $21.8K | 47,072 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | M Exercise | 2020-11-18 | 2020-11-18 | 848 | $18.30 | $15.5K | 47,696 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | M Exercise deriv | 2020-11-16 | 2020-11-18 | 562 | — | $0 | 71,938 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | M Exercise deriv | 2020-11-16 | 2020-11-18 | 10,000 | — | $0 | 105,117 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | M Exercise | 2020-11-16 | 2020-11-18 | 562 | $18.30 | $10.3K | 47,262 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2020-11-16 | 2020-11-18 | 2,020 | $33.75 | $68.2K | 50,295 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2020-11-16 | 2020-11-18 | 414 | $35.00 | $14.5K | 46,848 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | M Exercise | 2020-11-16 | 2020-11-18 | 10,000 | $6.83 | $68.3K | 52,315 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2020-11-16 | 2020-11-18 | 3,595 | $34.51 | $124.1K | 46,700 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | M Exercise deriv | 2020-11-04 | 2020-11-06 | 5,000 | — | $0 | 110,000 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2020-11-04 | 2020-11-06 | 3,364 | $28.00 | $94.2K | 42,315 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | M Exercise | 2020-11-04 | 2020-11-06 | 5,000 | $13.88 | $69.4K | 45,679 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | M Exercise deriv | 2020-10-15 | 2020-10-16 | 10,000 | — | $0 | 115,117 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | M Exercise | 2020-10-15 | 2020-10-16 | 10,000 | $6.83 | $68.3K | 46,294 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2020-10-15 | 2020-10-16 | 156 | $24.55 | $3.8K | 40,679 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2020-10-15 | 2020-10-16 | 5,459 | $24.19 | $132.1K | 40,835 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | M Exercise deriv | 2020-09-15 | 2020-09-17 | 10,000 | — | $0 | 125,117 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | M Exercise | 2020-09-15 | 2020-09-17 | 10,000 | $6.83 | $68.3K | 41,909 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2020-09-15 | 2020-09-17 | 5,615 | $21.04 | $118.1K | 36,294 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | M Exercise deriv | 2020-08-18 | 2020-08-20 | 10,000 | — | $0 | 135,117 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | M Exercise | 2020-08-18 | 2020-08-20 | 10,000 | $6.83 | $68.3K | 37,524 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2020-08-18 | 2020-08-20 | 5,615 | $21.00 | $117.9K | 31,909 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | M Exercise deriv | 2020-07-15 | 2020-07-17 | 10,000 | — | $0 | 145,117 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | M Exercise | 2020-07-15 | 2020-07-17 | 10,000 | $6.83 | $68.3K | 33,139 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2020-07-15 | 2020-07-17 | 5,615 | $22.70 | $127.5K | 27,524 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | M Exercise deriv | 2020-06-16 | 2020-06-18 | 10,000 | — | $0 | 155,117 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2020-06-16 | 2020-06-18 | 5,615 | $21.00 | $117.9K | 22,282 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | M Exercise | 2020-06-16 | 2020-06-18 | 10,000 | $6.83 | $68.3K | 27,897 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | M Exercise deriv | 2020-05-26 | 2020-05-28 | 10,000 | — | $0 | 165,117 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | M Exercise | 2020-05-26 | 2020-05-28 | 10,000 | $6.83 | $68.3K | 285,722 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2020-05-26 | 2020-05-28 | 5,615 | $21.21 | $119.1K | 280,107 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award deriv | 2020-03-02 | 2020-03-04 | 125,000 | — | $0 | 125,000 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award deriv | 2018-12-18 | 2018-12-20 | 71,000 | — | $0 | 71,000 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award deriv | 2018-01-25 | 2018-01-29 | 25,000 | — | $0 | 25,000 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award deriv | 2017-12-12 | 2017-12-14 | 72,500 | — | $0 | 72,500 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award | 2017-06-01 | 2017-06-05 | 8,400 | $12.03 | $101.1K | 8,994 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award deriv | 2017-01-06 | 2017-01-10 | 115,000 | — | $0 | 115,000 | SEC↗ |